Huyi Zhang

Articles by Huyi Zhang

Appendix: Common Deficiencies Related to Solution NMR in the Type-II DMFs

ByDavid J. Skanchy,Huyi Zhang,Jizhou Wang,Neeru Takiar

February 2nd 2017

Appendix to Characterization of Small-Molecule Drug Substances in Type II DMFs Supporting ANDAs, Part I: Solution Nuclear Magnetic Resonance Spectroscopy

Pages-from-PTeBook0316_046-054_Generics_DMFs_Subburaj.jpg

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

ByDavid J. Skanchy,Kandasamy Subburaj,Srinivasa Murthy,Humcha Hariprakasha,Brian T. Connell,Huyi Zhang,Deborah F. Johnson

March 15th 2016

The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.

Latest Updated Articles

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances
Published: March 15th 2016 | Updated:
Appendix: Common Deficiencies Related to Solution NMR in the Type-II DMFs
Published: February 2nd 2017 | Updated:

Huyi Zhang

Articles by Huyi Zhang

Appendix: Common Deficiencies Related to Solution NMR in the Type-II DMFs

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

Latest Updated Articles

Trending on Pharmaceutical Technology

Integrating Sustainability into the Core of Pharmaceutical Science

Outsourcing Partners Providing End-to-End Service

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards